Prof. Groop (Helsinki, Finland)

The benefit of linagliptin for a patient with diabetes is that I know what to expect in terms of efficacy. I know what to expect in terms of safety. And I know what to expect in terms of how easy it’s to use. I can use one dose in any patient with… irrespective of renal function and even irrespective of the hepatic function and I know what to achieve and expect in terms of reduction of A_1c and that’s, of course, a benefit not only for the patient but also for the doctor because you know what to expect.